Who owns EIGER BIOPHARMACEUTICALS INC?
- CUSIP Number: 28249u204
Tip: Access positions for across all investors
Analyze quarterly positions in Eiger Biopharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Eiger Biopharmaceuticals stock
Who bought or sold EIGER BIOPHARMACEUTICALS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Ameriprise Financial | 250k | $1.3M | 100% | Mar 2024 |
|
| Propel Bio Management | 146k | $732k | 100% | Mar 2024 |
|
| Simplify Asset Management | 90k | $450k | 100% | Mar 2024 |
|
| Accretive Wealth Partners | 63k | $170k | 100% | Mar 2024 |
|
| 683 Capital Management | 30k | $148k | 100% | Mar 2024 |
|
| Vanguard Group | 28k | $141k | 100% | Mar 2024 |
|
| BlackRock | 19k | $96k | 100% | Mar 2024 |
|
| Geode Capital Management | 13k | $63k | 100% | Mar 2024 |
|
| Rbf Capital | 11k | $55k | 100% | Mar 2024 |
|
| Tower Research Capital | 1.9k | $9.7k | 100% | Mar 2024 |
|
| Bank of America Corporation | 1.2k | $5.9k | 100% | Mar 2024 |
|
| Acadian Asset Management | 1.1k | $5.0k | 100% | Mar 2024 |
|
| Morgan Stanley | 366.00 | $1.8k | 100% | Mar 2024 |
|
| Royal Bank of Canada | 362.00 | $2.1k | 100% | Mar 2024 |
|
| Advisor Group Holdings | 331.00 | $1.7k | 100% | Mar 2024 |
|
| Bnp Paribas Arbitrage, Snc | 94.00 | $470.000000 | 100% | Mar 2024 |
|
| Federation des caisses Desjardins du Quebec | 12.00 | $60.000000 | 100% | Mar 2024 |
|
| Toth Financial Advisory Corporation | 11.00 | $55.999900 | 100% | Mar 2024 |
|
| Wells Fargo & Company | 10.00 | $50.000000 | 100% | Mar 2024 |
|
| UBS Group | 9.00 | $45.000000 | 100% | Mar 2024 |
|
| Jpmorgan Chase & Co | 5.00 | $25.000000 | 100% | Mar 2024 |
|
| Citigroup | 4.00 | $20.000000 | 100% | Mar 2024 |
|